MD
Malcom Deane
ALS Limited | Chief Strategy Officer, General Manager, Life Sciences - Food & Pharma Americas, General, Chief Executive Officer, Managing Director
Company and Roles
Company | Title | Tenure | Since |
|---|---|---|---|
![]() ALS Limited |
| 3yrs, 4mth | Mar 2023 |
Holding
Company | Last Notice | Direct Shares | Indirect Shares | Options | Convertibles |
|---|---|---|---|---|---|
![]() ALS Limited | 01/07/26 | 208,553 | N/A | N/A | N/A |
Transactions
Company | Date | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
![]() ALS Limited | 01/07/26 | Buy | 145,177 | $23.030 | $3,343,426 | Conversion of securities |
![]() ALS Limited | 01/07/26 | Issued | 27,883 | $23.030 | $642,145 | Issue of securities |
![]() ALS Limited | 01/07/26 | Exercise | 145,177 | $23.030 | $3,343,426 | Conversion of securities |
![]() ALS Limited | 01/07/26 | Expiry | 49,181 | $23.030 | $1,132,638 | As advised by the company |
![]() ALS Limited | 02/12/25 | Sell | 7,356 | $21.930 | $161,317 | On-market trade |
Any feedback about this profile? Contact Us
